Abeona Therapeutics Inc vs Autodesk Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Autodesk Inc trades at $249.34 (market cap $53.12B). The key difference: Autodesk Inc is far larger — about 126.1× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ADSK | |
|---|---|---|
Market Cap | $421.19M | $53.12B |
Sector | Health | Technology |
52-Week High | $7.45 | $326.79 |
52-Week Low | $4.17 | $187.72 |
Enterprise Value | $276.10M | $52.92B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →